BFS
CRDL

Boyer Financial Services’s Cardiol Therapeutics CRDL Stock Holding History

Boyer Financial Services’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35.8K Buy
34,100
+11,000
+48% +$13.9K 0.03% 56
2026
Q1 		$31.2K Sell
23,100
-10,000
-30% -$10.3K 0.03% 42
2025
Q4 		$32.9K Buy
+33,100
New +$34.7K 0.03% 49

Other funds holding CRDL

IA
Integrity Alliance Urbandale, Iowa $3.2B AUM 23.28% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
BWG
Boomfish Wealth Group Alpharetta, Georgia $220M AUM 23.55% 1-Year Est. Return
EFH
Eaton Financial Holdings Coral Springs, Florida $364M AUM 26.87% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Boyer Financial Services's CRDL Position: Q2 2026 in Review

Boyer Financial Services increased its Cardiol Therapeutics (CRDL) stake by 48% in Q2 2026, buying an estimated $13.9K and bringing the position to 34,100 shares worth $35.8K. The position accounts for 0.03% of the portfolio, ranked #56.

Boyer Financial Services first reported a position in CRDL in Q4 2025 and has held it in 3 quarters since. 17 funds tracked by Wall St. Rank hold CRDL as of Q2 2026.

  • Boyer Financial Services held 34,100 shares of Cardiol Therapeutics worth $35.8K as of Q2 2026.
  • Boyer Financial Services bought 11,000 Cardiol Therapeutics shares in Q2 2026, an estimated $13.9K.
  • Cardiol Therapeutics made up 0.03% of Boyer Financial Services's portfolio in Q2 2026, its #56 holding.
  • Boyer Financial Services first reported a position in Cardiol Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 17 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2026.

Based on Boyer Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.